This list is an analysis based on recent market events. It's not an investment recommendation.
About
EQL Pharma AB (publ) engages in the development, marketing, and sale of generic medicines to pharmacies and hospitals in Sweden, Denmark, Norway, Finland, and the rest of Europe. It offers prescription drugs, including hospital products. EQL Pharma AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
Show more...
CEO
Mr. Christer Fahraeus B.Sc. Maths, h.c., MSc Bio Eng, Ph.D.
The current price of 7JK.MU is €2.31 EUR — it has decreased by -2.94% in the past 24 hours. Watch EQL Pharma AB stock price performance more closely on the chart.
What is EQL Pharma AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange EQL Pharma AB stocks are traded under the ticker 7JK.MU.
Is EQL Pharma AB stock price growing?▼
7JK.MU stock has fallen by -5.71% compared to the previous week, the month change is a +22.48% rise, over the last year EQL Pharma AB has showed a -69.48% decrease.
What is EQL Pharma AB market cap?▼
Today EQL Pharma AB has the market capitalization of 68.21M
When is the next EQL Pharma AB earnings date?▼
EQL Pharma AB is going to release the next earnings report on November 05, 2026.
What were EQL Pharma AB earnings last quarter?▼
7JK.MU earnings for the last quarter are 0.01 EUR per share, whereas the estimation was -0 EUR resulting in a +375% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is EQL Pharma AB revenue for the last year?▼
EQL Pharma AB revenue for the last year amounts to 39.43M EUR.
What is EQL Pharma AB net income for the last year?▼
7JK.MU net income for the last year is 1.14M EUR.
How many employees does EQL Pharma AB have?▼
As of September 04, 2026, the company has 23 employees.
In which sector is EQL Pharma AB located?▼
EQL Pharma AB operates in the Health & Wellness sector.
When did EQL Pharma AB complete a stock split?▼
EQL Pharma AB has not had any recent stock splits.